AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H433-H440, 2008. First published November 16, 2007; doi:10.1152/ajpheart.01165.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Video
Right arrow All Versions of this Article:
294/1/H433    most recent
01165.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Diego, C.
Right arrow Articles by Valderrábano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Diego, C.
Right arrow Articles by Valderrábano, M.

Cardiac alternans in embryonic mouse ventricles

Carlos de Diego,* Fuhua Chen,* Lai-Hua Xie, Amish S. Dave, Mya Thu, Christine Rongey, James N. Weiss, and Miguel Valderrábano

Cardiovascular Research Laboratory, Departments of Medicine (Cardiology) and Pediatrics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California

Submitted 8 October 2007 ; accepted in final form 7 November 2007

T-wave alternans, an important arrhythmogenic factor, has recently been described in human fetuses. Here we sought to determine whether alternans can be induced in the embryonic mouse hearts, despite its underdeveloped sarcoplasmic reticulum (SR) and, if so, to analyze the response to pharmacological and autonomic interventions. Immunohistochemistry confirmed minimal sarcoplasmic-endoplasmic reticulum Ca-ATPase 2a expression in embryonic mouse hearts at embryonic day (E) 10.5 to E12.5, compared with neonatal or adult mouse hearts. We optically mapped voltage and/or intracellular Ca (Cai) in 99 embryonic mouse hearts (dual mapping in 64 hearts) at these ages. Under control conditions, ventricular action potential duration (APD) and Cai transient alternans occurred during rapid pacing at an average cycle length of 212 ± 34 ms in 57% (n = 15/26) of E10.5-E12.5 hearts. Maximum APD restitution slope was steeper in hearts developing alternans than those that did not (2.2 ± 0.6 vs. 0.8 ± 0.4; P < 0.001). Disabling SR Cai cycling with thapsigargin plus ryanodine did not significantly reduce alternans incidence (44%, n = 8/18, P = 0.5), whereas isoproterenol (n = 14) increased the incidence to 100% (P < 0.05), coincident with steepening APD restitution slope. Verapamil abolished Cai transients (n = 9). Thapsigargin plus ryanodine had no major effects on Cai-transient amplitude or its half time of recovery in E10.5 hearts, but significantly depressed Cai-transient amplitude (by 47 ± 8%) and prolonged its half time of recovery (by 18 ± 3%) in E11.5 and older hearts. Embryonic mouse ventricles can develop cardiac alternans, which generally is well correlated with APD restitution slope and does not depend on fully functional SR Cai cycling.

calcium cycling; cardiac development



Address for reprint requests and other correspondence: J. N. Weiss, Division of Cardiology, 3645 MRL Bldg., David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 (e-mail: jweiss{at}mednet.ucla.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.